What is the recommended evaluation and management plan for a newborn diagnosed with Noonan syndrome?

Management of Noonan Syndrome in Newborns

A newborn with Noonan syndrome requires immediate cardiac evaluation with echocardiogram and ECG, genetic confirmation, and systematic multidisciplinary screening for associated complications, with close monitoring for myeloproliferative disorder in the first year of life if specific high-risk mutations are present.

Initial Diagnostic Evaluation

Cardiac Assessment (Priority #1)

• Obtain echocardiogram and ECG at diagnosis 1, 2, 3
• Pulmonary stenosis occurs in approximately 48% of cases, often with dysplastic valve morphology 1, 2
• Hypertrophic cardiomyopathy is the second most common cardiac finding 3
• Biventricular hypertrophy and right ventricular free wall thickening are characteristic features 3
• Cardiology consultation is mandatory if any murmur or cardiac abnormality detected 4

The dysplastic pulmonary valve in Noonan syndrome differs from typical dome-shaped stenosis—it has poorly mobile, myxomatously thickened leaflets without commissural fusion, and the pulmonary annulus may also be narrowed 1. This distinction matters because dysplastic valves respond less favorably to balloon valvuloplasty.

Genetic Confirmation

• Molecular testing should be performed to confirm diagnosis 5, 6
• PTPN11 mutations account for ~50-61% of cases 5, 7
• Other genes include SOS1, RAF1, RIT1, LZTR1, KRAS, and others 8, 5
• Specific PTPN11 mutations (particularly codon 61, T73I) and KRAS T58I carry high risk for myeloproliferative disorder 8, 9
• If initial gene panel is negative, consider chromosome microarray 4

Surveillance for Myeloproliferative Disorder

For infants with high-risk PTPN11 (codon 61, T73I) or KRAS (T58I) mutations:

• Physical examination with hepatosplenomegaly assessment every 3 months through age 1 year 8, 9
• Obtain CBC with differential only if infant is ill or has hepatosplenomegaly on exam—do not perform routine bloodwork in asymptomatic infants 8
• If bloodwork is abnormal, immediate hematology consultation 8
• NS-associated myeloproliferative disorder typically presents in neonates/young infants and often self-resolves, but can transform to aggressive JMML requiring treatment 9, 10

Comprehensive Multisystem Evaluation

Feeding and Growth

• Assess for poor feeding—common in infancy and requires early intervention 5, 7
• Document growth parameters and establish growth trajectory
• Consider early childhood intervention referral 4

Neurologic Assessment

• Baseline neurologic evaluation 4
• Screen for hypotonia, developmental delays 4, 5
• Brain MRI indicated only if rapid head growth, seizures, or neurologic changes 4

Additional Baseline Studies

• Complete eye examination 7
• Hearing evaluation 7
• Assess for cryptorchidism in males (present in ~60%) 11
• Dermatologic examination for lymphedema, skin abnormalities 4
• Coagulation studies before any surgical procedure—bleeding tendency is common 7

Ongoing Management Schedule

Infancy (0-1 year)

• Cardiology follow-up every 2-3 months if cardiac disease present
• 24-hour Holter monitoring if arrhythmias detected 4
• Physical therapy for hypotonia and motor delays 4
• Occupational therapy for feeding difficulties 4

Childhood (1-20 years)

• Repeat echocardiogram every 2-3 years even if initially normal 4
• Blood pressure measurement at each visit 4
• Annual follow-up with genetics provider 4
• Neuropsychological evaluation upon school entry 4
• Develop Individualized Education Plan as needed 4

Critical Pitfalls to Avoid

1. Never assume normal cardiac function based on physical exam alone—echocardiogram is mandatory as murmurs may be subtle or absent
2. Do not perform routine CBC screening in asymptomatic infants without high-risk mutations—this leads to unnecessary anxiety and testing 8
3. Recognize that dysplastic pulmonary valves require different management than typical stenosis—balloon valvuloplasty has higher failure rates 1
4. Always obtain coagulation studies before surgery or procedures—bleeding diathesis is underrecognized 7
5. Do not delay genetic testing—molecular confirmation guides cancer surveillance and prognosis 6

Anesthesia Considerations

• Cardiac evaluation within 3-6 months before any anesthesia or sedation 12
• Anesthesiologist experienced in Noonan syndrome should be involved for major surgery 12
• Procedure should occur at center with appropriate intensive care facilities 12

Cancer Surveillance Beyond Infancy

• Increased awareness for symptoms of neuroblastoma, rhabdomyosarcoma, brain tumors 8, 9
• No routine imaging surveillance recommended for standard NS cases 8
• Maintain low threshold for investigating new concerning symptoms 9